Delivery Order SPE2DB24D2013-SPE2DB25FCHZE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors valued at $2,934.71. This is a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,439.29 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injectors with a completion date of July 29, 2025. This firm fixed-price delivery order, issued on July 28, 2025, represents a competitively awarded contract with no set-aside designation. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $4,353.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under a larger indefinite delivery vehicle that enables DLA to...
- The Defense Logistics Agency awarded a delivery order valued at $2,405.78 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on June 18, 2025, with a completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $12,402.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on September 2, 2025, with completion scheduled for September 3, 2025. This non-set-aside contract represents a small-value pharmaceutical supply order to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $13,780.15 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on July 21, 2025, with completion targeted for July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $6,044.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The contract specifies a completion date of July 31, 2025, and lists the place of performance as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $4,353.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on March 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). This is a non-set-aside competitive award with an ultimate completion date of March 17, 2025, and represents performance by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $8,906.71 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors. This firm fixed price contract, with an ultimate completion date of April 25, 2025, represents a single-award delivery order with no set-aside designation, awarded through competitive procurement. The contract is executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $34,843.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors. The contract, which is a child order under a larger indefinite delivery vehicle, has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation....
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCHZEDelivery Order
The Defense Logistics Agency awarded a $4,241.13 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml units). This is a firm fixed-price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion on April 25, 2025, with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive IDC vehicle to supply a broad range of medications, vaccines, and medical supplies globally. The Mounjaro supply supports the Defense Health Agency and other government healthcare systems in fulfilling pharmaceutical needs across military installations. As a major for-profit pharmaceutical distributor registered in the System for Award Management, AmerisourceBergen has demonstrated sustained capability to meet federal procurement requirements across multiple therapeutic domains through competitive contract awards with consistent firm fixed-price delivery order mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 4/24/25 |